Latest News
Friday preview: US non-farm payrolls, Hargreaves Lansdown in focus
All eyes will be on the latest US non-farm payrolls report at the end of the week as investors around the world try to gauge the extent of the slowdown in the US recovery from the pandemic.
US close: Stocks continue rally following surprise jobless figures
Wall Street stocks closed higher on Thursday after this week's initial jobless claims report revealed a surprise decline to their lowest level since the onset of the pandemic and a tech rally late in the session gave indices a boost.
London close: Stocks finish lower as BoE stands pat on rates
London stocks closed on the red on Thursday, after the Bank of England stood pat on interest rates and warned the economic recovery would take longer than expected.
Goldman Sachs thinks markets underpricing odds for Covid-19 vaccine before year end
Goldman Sachs thinks the world will be in a very different place in three months' time on at least three front, so much so that investors' expectations for the outcomes will likely set the tone for trading until then.
Director dealings: Workspace chairman makes share purchase
Workspace revealed on Thursday that chairman Stephen Hubbard had acquired 8,350 ordinary shares in the FTSE 250-listed office space provider.
Broker tips: XP Power, Hummingbird Resources, Rotork
Liberum initiated coverage on electrical component manufacturer XP Power at 'buy' on Thursday, stating that an acceleration in earnings growth would drive a re-rating in the group's shares.
Berenberg nudges up target price on Hummingbird Resources
Analysts at Berenberg slightly raised their target price on precious metals miner Hummingbird Resources from 44. 0p to 50. 0p on Thursday after the group maintained its full-year guidance following an in-line second quarter of trading.
Citi hikes target on Rotork, says 2021 estimates were 'too punitive'
Citi analysts revised their target price for shares of flow control specialist Rotork's shares, telling clients that they had been far too harsh when it came to their estimates for the following year.
US open: Mostly flat start to trading following surprise jobless reading
Wall Street trading was broadly flat following the opening bell on Thursday after this week's initial jobless claims report revealed a surprise decline to their lowest level since the onset of the pandemic.
Jubilee secures rights to process 2m tonnes of copper run-of-mine
Jubilee Metals Group has signed a joint venture agreement with a private Zambia company, it announced on Thursday, securing the rights to process two million tonnes of copper run-of-mine material containing more than 2% copper.
Mobile Streams pleased with progress as it focuses on data business
Mobile content and data intelligence company Mobile Streams updated the market on its trading for the year ended 30 June on Thursday, describing it as one of “significant change”.
All Epwin Group manufacturing and distribution sites reopen
Low-maintenance building products company Epwin Group updated the market on its first half of trading on Thursday, reporting that all of its manufacturing and distribution sites had returned to operation, with additional Covid safe-working practices implemented.
Aston Martin no longer at risk of near-term liquidity crisis, S&P says
Analysts at Standard Poor's raised their rating on Aston Martin's long-term debt, telling clients the company was no longer vulnerable to a "liquidity crisis" over the next six to 12 months.
FTSE 250 movers: Hammerson heads lower; XP Power boosted by broker note
London’s FTSE 250 was down 1% at 17,469. 07 in afternoon trade on Thursday.
FTSE 100 movers: Glencore slumps on results; Aviva rallies
London’s FTSE 100 was down 1. 5% at 6,016. 29 in afternoon trade on Thursday.
Weekly US jobless claims surprise to the downside
Jobless claims in America unexpectedly broke significantly lower over the preceding week.
GSK receives FDA approval for blood cancer drug
Pharmaceutical giant GlaxoSmithKline has received approval from the US Food and Drug Administration for the use of belantamab mafodotin-blmf (BLENREP) in the treatment of patients with relapsed or refractory multiple myeloma.
Europe midday: Stocks drop as opening bell approaches in US, talks on Capitol Hill in focus
Selling in European stocks intensified on Thursday as investors kept an eye on talks on Capitol Hill on a fourth fiscal stimulus package and despite reports of some concessions from Republicans.
Fulham Shore reopens majority of sites, sales on the rise
Franco Manca owner Fulham Shore said on Thursday that the majority of its sites had now reopened, with sales rising week-on-week since 4 July.
Activist Bramson keeps up pressure on Barclays
Activist investor Edward Bramson has called for Barclays to shrink its investment bank by almost a quarter as he continues to agitate for change at the company.